The Latest Cardiac and Vascular News
The trial will generate critical clinical evidence and discovery for the novel medical device. MINNEAPOLIS, May 18, 2026 /PRNewswire/ — EmStop, Inc., a cardiovascular medical device company, announced the initiation of the CAPTURE-2 Investigational Device Exemption (IDE) clinical trial…
Trial completion marks an important milestone in the development of the next generation, embolic protection platform MINNEAPOLIS, Nov. 21, 2024 /PRNewswire/ — Cardiovascular medical device company, EmStop, Inc., today announced the completion of the CAPTURE-1 early feasibility clinical…
Ebeling brings more than 30 years of experience to the cardiovascular medical device company MINNEAPOLIS, Aug. 5, 2024 /PRNewswire/ — Cardiovascular medical device company, EmStop, today announced the appointment of Board Member Phil Ebeling as the company’s new President and Chief…
